AVR 2.97% $12.15 anteris technologies ltd

Ann: Data Update on First-in-Human Study of DurAVR at NY Valves, page-20

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 201 Posts.
    lightbulb Created with Sketch. 12
    Didn't Wayne say in a recent interview that they spoke with FDA to include one Australian centre in the pivotal study and they agreed?
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.